Form 4: Columbia Financial Inc. Executive Jenifer White Walden Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


EVP & CHRO Jenifer White Walden reports acquisition of common stock and vesting of stock options in Columbia Financial, Inc.

Summary

  • On May 3, 2024, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc., reported changes in beneficial ownership of the company's stock.
  • Walden acquired common stock through a stock-based deferral plan at a price of $15.73 per share, resulting in the acquisition of 33.8646 shares.
  • Walden directly owns 1,359 shares of common stock.
  • Walden indirectly owns shares through various plans including the ESOP (982 shares), SERP (45 shares), SIM (14 shares), Stock Award (1,298 shares), Stock Award II (7,817 shares), and Stock Award III (7,597 shares).
  • Walden holds stock options to purchase 5,540 shares at $20.54 (exercisable from October 31, 2023), 6,203 shares at $15.94 (exercisable from May 1, 2024), and 5,107 shares at $16.49 (exercisable from March 6, 2025).

Sentiment

Score: 5

Explanation: The document is a standard SEC filing, indicating neutral sentiment. It simply reports transactions without expressing any positive or negative outlook.

Positives

  • The acquisition of shares through the stock-based deferral plan indicates Walden's continued investment in the company's future.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in the financial industry.

Comparison to Industry Standards

  • Executive stock ownership and option grants are standard practice in publicly traded companies like Columbia Financial, Inc.
  • Similar filings are regularly made by executives at comparable institutions such as OceanFirst Financial Corp. and Investors Bancorp, Inc.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and ownership.

Key Dates

DateDescription
10/31/2023Commencement of vesting for stock options with an exercise price of $20.54.
05/03/2024Date of transaction: acquisition of common stock through stock-based deferral plan.
05/01/2024Commencement of vesting for stock options with an exercise price of $15.94.
03/06/2025Commencement of vesting for stock options with an exercise price of $16.49.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.